Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 1 - 20 of 472
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2024, 11:47 am by Kurt R. Karst
PLAINTIFF COURT AND DATE OF COMPLAINT SELECTED DRUGS (FOR YEAR 2026) Bristol Myers Squibb D.N.J. (16 June 2023) Eliquis Novartis D.N.J. (1 Sept. 2023) Entresto J&J’s Janssen Pharms. [read post]
Then, led by a passion for helping bring teams together, I moved into my first DEI role at Bristol-Myers Squibb in 2002. [read post]
29 Jan 2024, 4:35 pm
https://responsibletechnology.org/ge-soil-microbes-new-target-for-agrichemical- companies/ Rhinos cont'd. [read post]
4 Oct 2023, 10:00 pm by Kurt R. Karst
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
Recounting the early days of his career, after graduating from Rutgers University, Andrews spent nine years working as an account manager in group insurance at Prudential Financial before moving into his first DEI role at Bristol-Myers Squibb in 2002. [read post]
Recounting the early days of his career, after graduating from Rutgers University, Andrews spent nine years working as an account manager in group insurance at Prudential Financial before moving into his first DEI role at Bristol-Myers Squibb in 2002. [read post]
18 Sep 2023, 9:01 pm by Rodger Citron and Laura Dooley
 Justice Sotomayor’s vote here was consistent with her dissent in a 2017 case involving suits filed by individuals from different states against Bristol-Myers Squibb (“BMS”) in California state court. [read post]
17 Sep 2023, 10:31 pm by Scott McKeown
The panel features:• Yen Florczak, Chief Intellectual Property Counsel at 3M Company• Henry Hadad, Senior Vice President and Deputy General Counsel at Bristol-Myers Squibb• Samir Pandya, Head of IP Litigation at SAP (Register here) Questions can be sent in advance to PTABBoardsideChat@uspto.gov [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
  The facts Patent EP1427415 (“EP’415″) was filed in the name of Bristol-Myers Squibb Company (“BMS Company”) on September 17, 2002 in the form of international application PCT/US02/29491 (WO 03/026652) (“WO’652”), under the priority of provisional application US 60/324,165 of September 21, 2001. [read post]
19 Jun 2023, 8:57 am by Site Admin
The former Bristol Myers Squibb site in Hopewell Township, east of Pennington Borough is currently being developed by BeiGene pharmaceutical company with the construction of new labs. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
25 May 2023, 1:24 am
 Jane LambertCourt of Appeal (Lord Justices Arnold, Nugee and Warby) Sandoz Ltd v Bristol-Myers Squibb Holdings Ireland Unlimited Company[2023] EWCA Civ 472 (4 May 2023)This was an appeal by Bristol Myers Squibb Ireland ("BMS") against Mr Justice Meade's judgment in  Sandoz Ltd and another v Bristol-Myers Squibb Holdings Ireland (Unlimited) Company [2022] EWHC 822 (Pat)… [read post]
20 Mar 2023, 7:52 am by Rebecca Tushnet
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
25 Jan 2023, 1:37 pm by Kevin LaCroix
The settlement listed in the hundred spot on the list is 2006 settlement of $185 million in the Bristol-Myers Squibb Co. case. [read post]
23 Jan 2023, 4:02 am by Berniard Law Firm
In October, 2014 Jenkins filed a lawsuit for damages against Bristol-Myers Squibb Company and Otsuka American Pharmaceutical Inc., the makers of Abilify. [read post]
6 Jan 2023, 2:33 pm by anne
Bristol-Myers Squibb paying $75 million to resolve allegations was the seventh largest Healthcare Fraud recovery on last year’s list. [read post]
9 Nov 2022, 1:00 pm by Holly Brezee
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]